Chicago IL 精神分裂症临床试验
20项针对 精神分裂症的研究正在 Chicago及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)
招募中3 期
- EmVenio Research Center - Prime Healthcare, Chicago
A Study to Evaluate the Effect of KarXT on Urological Safety
招募中4 期
- Uptown Research Institute, Chicago
- Pillar Clinical Research -Chicago, Chicago
Cognitive Neurocomputational Task Reliability & Clinical Applications Consortium (CNTRACS): Study 1
招募中欢迎健康志愿者
- The University of Chicago, Chicago
A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
招募中3 期
- EmVenio Research Center - Prime Healthcare, Chicago
A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With Schizophrenia
招募中1 期
- Uptown Research Institute, Chicago
Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
招募中3 期
- Local Institution - 0067, Chicago
- Pillar Clinical Research -Chicago, Chicago
A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
招募中2 期
- Clinical Site, Chicago
A Study of Brenipatide in Adult Participants With Schizophrenia
招募中2 期
- Re:Cognition Health - Chicago, Chicago
NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
招募中3 期
- Neurocrine Clinical Site, Chicago
52-week Open Label Safety-Tolerability Study
招募中3 期
- Pillar Clinical Research, Chicago
A Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT
招募中1 期
- Uptown Research Institute, Chicago
Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
招募中3 期
- Alkermes Investigator Site, Chicago
Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia
招募中2 期
- Uptown Research Institute LLC, Chicago
- Pillar Clinical Research LLC, Chicago
Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia
招募中3 期
- Pillar Clinical Research, Chicago
CLOZAPINE Response in Biotype-1
招募中4 期
- University of Chicago, Chicago
Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
招募中观察性研究
- University of Chicago Medical Center, Chicago
NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
招募中3 期
- Neurocrine Clinical Site, Chicago
Randomized Withdrawal Study in Patients With Schizophrenia
招募中3 期
- Vanda Investigational Site, Chicago
Study of ALTO-101 in Patients With Schizophrenia
招募中2 期
- Site 5056, Chicago
Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
招募中3 期欢迎健康志愿者
- Reviva site, Chicago
其他城市的 精神分裂症试验
- Atlanta, GA21 项研究
- Little Rock, AR18 项研究
- San Diego, CA15 项研究
- Houston, TX14 项研究
- Boston, MA14 项研究
- Hollywood, FL14 项研究
- Hialeah, FL13 项研究
- Austin, TX12 项研究
- Garden Grove, CA12 项研究
- New York City, NY12 项研究
- Miami, FL10 项研究
- Germantown, MD10 项研究
Chicago的其他研究
- 乳腺癌59 项研究
- 非小细胞肺癌59 项研究
- 癌症（所有类型）51 项研究
- 前列腺癌45 项研究
- 肺癌43 项研究
- 转移性癌症42 项研究
- 肥胖症40 项研究
- 卵巢癌36 项研究
- 结直肠癌32 项研究
- 卒中31 项研究
- 头颈鳞状细胞癌29 项研究
- 超重29 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年11月15日。每项研究自行设定入选标准，由研究团队决定谁能参与。